TLR9 and Sepsis: Despite debate on the use of hydroxychloroquine in sepsis, especially in acute respiratory distress syndrome from Coronavirus (COVID-19) infection [86,87], there might be some sepsis conditions that are beneficial from TLR-9 inhibition and bacterial DNA neutralization [88].